iSpecimen (ISPC) Net Cash Flow (2020 - 2026)

iSpecimen (ISPC) has reported Net Cash Flow for 7 consecutive years, with -$4.1 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Net Cash Flow fell 270.66% year-over-year to -$4.1 million; the TTM figure through Mar 2026 stood at $2.0 million (up 255.89% YoY), while the FY2025 annual figure was $5.0 million, up 1175.19% from the prior year.
• Net Cash Flow came in at -$4.1 million for Q1 2026 at iSpecimen, down from $4.1 million in the prior quarter.
• The five-year high for Net Cash Flow was $4.1 million in Q4 2025, with the low at -$11.5 million in Q1 2023.
• Average Net Cash Flow over 5 years is -$1.5 million, with a median of -$399389.0 recorded in 2024.
• Across the five-year window, Net Cash Flow slumped 604.11% in 2023 and surged 3138.2% in 2025, its largest moves.
• Year by year, Net Cash Flow stood at -$5.3 million in 2022, then surged by 92.94% to -$377902.0 in 2023, then surged by 133.49% to $126554.0 in 2024, then soared by 3138.2% to $4.1 million in 2025, then sank by 199.12% to -$4.1 million in 2026.
• According to Business Quant data, Net Cash Flow over the past three periods registered -$4.1 million, $4.1 million, and $2.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.